Oct 29, 2019 4:05 pm EDT Eyenovia Advances MicroLine for the Treatment of Presbyopia Towards Phase III Development and Reprioritizes Late-Stage Ophthalmology Pipeline
Aug 6, 2019 8:30 am EDT Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results
Jul 16, 2019 4:05 pm EDT Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering
Jun 4, 2019 8:30 am EDT Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia